Massachusetts General Hospital implants Levacor Ventricular Assist Device

Download PDF Copy

Aug 16 2010

World Heart Corporation (WorldHeart) (Nasdaq:WHRT), a developer of mechanical circulatory systems, announced today that the Massachusetts General Hospital (Mass General) in Boston, Mass. has successfully implanted its first Levacor™ Ventricular Assist Device (VAD). Mass General is the fifth implanting site nationwide in the Levacor VAD Bridge-to-Transplant (BTT) Study. This is the eleventh implant with the Levacor VAD since the inception of the BTT study.

Dr. Thomas MacGillivray, cardiac surgeon and Mass General's surgical Principal Investigator for the study, commented, "Through the Levacor VAD Study we are able to offer late-stage heart failure patients another bridge-to-transplant treatment option."

Mr. J. Alex Martin, WorldHeart's President and Chief Executive Officer, added, "We are delighted that Mass General is now an active participating clinical site in the Levacor VAD BTT Study. This study provides access to next-generation blood pump technology for eligible heart-transplant candidates in the North-Eastern United States."

Source:

World Heart Corporation

Posted in: Device / Technology News | Medical Procedure News | Medical Condition News

Comments (0)

Download PDF Copy

Suggested Reading

Watch: Patient numbers at NIH hospital tumble after Trump cuts

New 'GLed' tool enables real-time monitoring of T cell activity

Study examines unplanned out-of-hospital deliveries in Styria, Austria

Massage Therapy Foundation funds CHOP study on pediatric irritable bowel syndrome

Deep brain stimulation shows promise in reducing severe stuttering

Big loopholes in hospital charity care programs mean patients still get stuck with the tab

Study validates deep learning model for predicting future lung cancer risk in Black population

Surgical hospital closures disproportionately hit poor and socially vulnerable communities

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

(Logout)

Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.